Abbott Laboratories (ABT)
Operating profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 6,825,000 | 6,478,000 | 8,362,000 | 8,425,000 | 5,357,000 |
| Revenue | US$ in thousands | 41,950,000 | 40,109,000 | 43,653,000 | 43,075,000 | 34,608,000 |
| Operating profit margin | 16.27% | 16.15% | 19.16% | 19.56% | 15.48% |
December 31, 2024 calculation
Operating profit margin = Operating income ÷ Revenue
= $6,825,000K ÷ $41,950,000K
= 16.27%
The operating profit margin of Abbott Laboratories has shown a positive trend over the period from December 31, 2020, to December 31, 2024. The margin increased from 15.48% in 2020 to 19.56% in 2021, indicating an improvement in the company's operational efficiency and profitability. Despite a slight decrease to 19.16% in 2022, the margin remained at a relatively high level. In 2023 and 2024, the operating profit margin declined to 16.15% and 16.27%, respectively, suggesting some challenges in maintaining profitability levels. Overall, Abbott Laboratories has demonstrated a strong operating profit margin, albeit with some fluctuations in recent years.
Peer comparison
Dec 31, 2024